Gangliosides and neurotrophic growth factors in the retina. Molecular interactions and applications as neuroprotective agents

H. Dreyfus, J. Sahel, V. Heidinger, S. Mohand-Said, B. Guerold, Emmanuelle Meuillet, V. Fontaine, D. Hicks

Research output: Contribution to journalArticle

18 Citations (Scopus)

Abstract

Polypeptide growth factors and gangliosides can both be considered as trophic agents involved in almost all stages of neural cell development, differentiation, survival, and pathology. In most cases their physiological roles are still not clear due to the considerable complexity in their regulation. Several growth factors [e.g., basic fibroblast growth factor (bFGF) and epidermal growth factor (EGF)] and one species of ganglioside (GM1) have been shown to exert interactions with each other and also to exhibit neuroprotective effects against retinal ischemia in vivo and cerebral excitotoxicity in vitro. Different experimental models are used to investigate their relevance to ischemic and excitotoxic conditions in the retina, and it is shown that (1) both bFGF and EGF show very effective neuroprotection for rat retinal neurones exposed to toxic levels of glutamate or its nonphysiological agonist kainate in vitro; (2) GM1 (10-5 M) used under the same conditions does not afford protection; (3) retinal glial cells also suffer morphological perturbations following glutamate or kainate treatment, but this effect is dependent on neuron-glial interactions, indicating the existence of intermediate neuron-derived messenger molecules; (4) these glial changes can be corrected by posttreatment with either bFGF or EGF in vitro; (5) using an in vivo animal model involving anterior chamber pressure-induced ischemia in adult rats, it is shown that either pretreatment by intraperitoneal injection of GM1, or posttreatment by intraocular injection of the same ganglioside, reduces significantly histological damage to inner nuclear regions; and (6) in cultured retinal Muller glial cells the existence of molecular and metabolic interactions between both types of trophic factors is demonstrated. Hence both these groups of trophic molecules show interesting features for retinal ischemic treatment.

Original languageEnglish (US)
Pages (from-to)240-252
Number of pages13
JournalAnnals of the New York Academy of Sciences
Volume845
DOIs
StatePublished - 1998
Externally publishedYes

Fingerprint

Molecular interactions
Gangliosides
Nerve Growth Factors
Neuroprotective Agents
Neuroglia
Retina
Intercellular Signaling Peptides and Proteins
Fibroblast Growth Factor 2
Epidermal Growth Factor
Neurons
Kainic Acid
Rats
Glutamic Acid
Ischemia
Intraocular Injections
Ependymoglial Cells
Retinal Neurons
G(M1) Ganglioside
Molecules
Poisons

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)

Cite this

Gangliosides and neurotrophic growth factors in the retina. Molecular interactions and applications as neuroprotective agents. / Dreyfus, H.; Sahel, J.; Heidinger, V.; Mohand-Said, S.; Guerold, B.; Meuillet, Emmanuelle; Fontaine, V.; Hicks, D.

In: Annals of the New York Academy of Sciences, Vol. 845, 1998, p. 240-252.

Research output: Contribution to journalArticle

Dreyfus, H. ; Sahel, J. ; Heidinger, V. ; Mohand-Said, S. ; Guerold, B. ; Meuillet, Emmanuelle ; Fontaine, V. ; Hicks, D. / Gangliosides and neurotrophic growth factors in the retina. Molecular interactions and applications as neuroprotective agents. In: Annals of the New York Academy of Sciences. 1998 ; Vol. 845. pp. 240-252.
@article{5dc64b26c18843df916e0d00c6681f54,
title = "Gangliosides and neurotrophic growth factors in the retina. Molecular interactions and applications as neuroprotective agents",
abstract = "Polypeptide growth factors and gangliosides can both be considered as trophic agents involved in almost all stages of neural cell development, differentiation, survival, and pathology. In most cases their physiological roles are still not clear due to the considerable complexity in their regulation. Several growth factors [e.g., basic fibroblast growth factor (bFGF) and epidermal growth factor (EGF)] and one species of ganglioside (GM1) have been shown to exert interactions with each other and also to exhibit neuroprotective effects against retinal ischemia in vivo and cerebral excitotoxicity in vitro. Different experimental models are used to investigate their relevance to ischemic and excitotoxic conditions in the retina, and it is shown that (1) both bFGF and EGF show very effective neuroprotection for rat retinal neurones exposed to toxic levels of glutamate or its nonphysiological agonist kainate in vitro; (2) GM1 (10-5 M) used under the same conditions does not afford protection; (3) retinal glial cells also suffer morphological perturbations following glutamate or kainate treatment, but this effect is dependent on neuron-glial interactions, indicating the existence of intermediate neuron-derived messenger molecules; (4) these glial changes can be corrected by posttreatment with either bFGF or EGF in vitro; (5) using an in vivo animal model involving anterior chamber pressure-induced ischemia in adult rats, it is shown that either pretreatment by intraperitoneal injection of GM1, or posttreatment by intraocular injection of the same ganglioside, reduces significantly histological damage to inner nuclear regions; and (6) in cultured retinal Muller glial cells the existence of molecular and metabolic interactions between both types of trophic factors is demonstrated. Hence both these groups of trophic molecules show interesting features for retinal ischemic treatment.",
author = "H. Dreyfus and J. Sahel and V. Heidinger and S. Mohand-Said and B. Guerold and Emmanuelle Meuillet and V. Fontaine and D. Hicks",
year = "1998",
doi = "10.1111/j.1749-6632.1998.tb09677.x",
language = "English (US)",
volume = "845",
pages = "240--252",
journal = "Annals of the New York Academy of Sciences",
issn = "0077-8923",
publisher = "Wiley-Blackwell",

}

TY - JOUR

T1 - Gangliosides and neurotrophic growth factors in the retina. Molecular interactions and applications as neuroprotective agents

AU - Dreyfus, H.

AU - Sahel, J.

AU - Heidinger, V.

AU - Mohand-Said, S.

AU - Guerold, B.

AU - Meuillet, Emmanuelle

AU - Fontaine, V.

AU - Hicks, D.

PY - 1998

Y1 - 1998

N2 - Polypeptide growth factors and gangliosides can both be considered as trophic agents involved in almost all stages of neural cell development, differentiation, survival, and pathology. In most cases their physiological roles are still not clear due to the considerable complexity in their regulation. Several growth factors [e.g., basic fibroblast growth factor (bFGF) and epidermal growth factor (EGF)] and one species of ganglioside (GM1) have been shown to exert interactions with each other and also to exhibit neuroprotective effects against retinal ischemia in vivo and cerebral excitotoxicity in vitro. Different experimental models are used to investigate their relevance to ischemic and excitotoxic conditions in the retina, and it is shown that (1) both bFGF and EGF show very effective neuroprotection for rat retinal neurones exposed to toxic levels of glutamate or its nonphysiological agonist kainate in vitro; (2) GM1 (10-5 M) used under the same conditions does not afford protection; (3) retinal glial cells also suffer morphological perturbations following glutamate or kainate treatment, but this effect is dependent on neuron-glial interactions, indicating the existence of intermediate neuron-derived messenger molecules; (4) these glial changes can be corrected by posttreatment with either bFGF or EGF in vitro; (5) using an in vivo animal model involving anterior chamber pressure-induced ischemia in adult rats, it is shown that either pretreatment by intraperitoneal injection of GM1, or posttreatment by intraocular injection of the same ganglioside, reduces significantly histological damage to inner nuclear regions; and (6) in cultured retinal Muller glial cells the existence of molecular and metabolic interactions between both types of trophic factors is demonstrated. Hence both these groups of trophic molecules show interesting features for retinal ischemic treatment.

AB - Polypeptide growth factors and gangliosides can both be considered as trophic agents involved in almost all stages of neural cell development, differentiation, survival, and pathology. In most cases their physiological roles are still not clear due to the considerable complexity in their regulation. Several growth factors [e.g., basic fibroblast growth factor (bFGF) and epidermal growth factor (EGF)] and one species of ganglioside (GM1) have been shown to exert interactions with each other and also to exhibit neuroprotective effects against retinal ischemia in vivo and cerebral excitotoxicity in vitro. Different experimental models are used to investigate their relevance to ischemic and excitotoxic conditions in the retina, and it is shown that (1) both bFGF and EGF show very effective neuroprotection for rat retinal neurones exposed to toxic levels of glutamate or its nonphysiological agonist kainate in vitro; (2) GM1 (10-5 M) used under the same conditions does not afford protection; (3) retinal glial cells also suffer morphological perturbations following glutamate or kainate treatment, but this effect is dependent on neuron-glial interactions, indicating the existence of intermediate neuron-derived messenger molecules; (4) these glial changes can be corrected by posttreatment with either bFGF or EGF in vitro; (5) using an in vivo animal model involving anterior chamber pressure-induced ischemia in adult rats, it is shown that either pretreatment by intraperitoneal injection of GM1, or posttreatment by intraocular injection of the same ganglioside, reduces significantly histological damage to inner nuclear regions; and (6) in cultured retinal Muller glial cells the existence of molecular and metabolic interactions between both types of trophic factors is demonstrated. Hence both these groups of trophic molecules show interesting features for retinal ischemic treatment.

UR - http://www.scopus.com/inward/record.url?scp=0031928905&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031928905&partnerID=8YFLogxK

U2 - 10.1111/j.1749-6632.1998.tb09677.x

DO - 10.1111/j.1749-6632.1998.tb09677.x

M3 - Article

C2 - 9668358

AN - SCOPUS:0031928905

VL - 845

SP - 240

EP - 252

JO - Annals of the New York Academy of Sciences

JF - Annals of the New York Academy of Sciences

SN - 0077-8923

ER -